Nasdaq GlobeNewswire

Biotech Marketplace ZAGENO Connects All Stakeholders - a 360° Approach

Del

BOSTON and BERLIN, Jan.  03, 2018  (GLOBE NEWSWIRE) -- ZAGENO Inc. offers a dynamic and industry-leading ecosystem for online ordering in the life science sector. In today's cluttered and nontransparent e-commerce setting, digitally streamlining purchasing processes has become increasingly crucial for all stakeholders. ZAGENO provides useful information for scientists, a decrease in internal costs for procurement departments, and increased reach towards high-potential target audiences for biotechnology vendors.

Life Science Marketplace Connects Major Stakeholders
ZAGENO was founded with the vision to connect scientists, administrative departments, and vendors of biotechnology products through one single platform. ZAGENO enables scientists to order research materials through a comprehensive e-commerce platform comparable to other online shopping websites for consumer products. ZAGENO's co-founders David Pumberger, Florian Wegener, and Kilian Veer established a holistic solution to satisfy all relevant stakeholders. The core of the ZAGENO engine is to fulfill scientists' needs and facilitate their decision-making processes by covering all touchpoints necessary to complete an order online. With the resulting advanced customer experience, ZAGENO laid the foundation for the start-up's accelerated traction with leading life science institutions, academic research environments, and life science research companies.

360° Purchasing Decisions - Bundling Crucial Information
To arrive at well-informed conclusions during the purchasing process is not always easy for scientists. After all, to question the obvious, go the extra mile, and strive for new insights is a personality trait one needs for a successful career in research. To better understand what is crucial for success in this environment, we analyzed scientists' purchasing behavior and brought together three components necessary for a thriving, digital life science marketplace: Content, Community, and Commerce.

Content, Community, and Commerce in Life Science Research
For ZAGENO, content means compiling product specifications from vendors, enabling product comparisons across manufacturers, and enhancing product descriptions and specifications where needed. ZAGENO's expert biotech team curates product details using machine learning software to deliver the best results. Furthermore, a patent-pending "Scientific Score" tells customers how widely used a specific product is and, for example, how many times the product has appeared in peer-reviewed publications.

Globally Accessible High-Value Community Knowledge
Community translates into building a holistic resource for scientists where they can exchange thoughts about products, get support via ZAGENO's unique biotech expert live chat, and access high-quality scientific content available to everyone. Early in 2018, ZAGENO will launch an ISSN-registered peer-review journal (EUREKA! Methods) that will be different from the majority of existing journals in one major respect: access and publishing will be free of charge. This will open opportunities for life science researchers in emerging markets and to scientific and academic institutions that lack adequate funding. With the launch of EUREKA! Methods, the start-up is approaching its next milestone in becoming a global and growing authority in the fields of life science research.

The ZAGENO Ecosystem for Life Science Ordering Online
A new, interconnected biotechnology e-commerce experience is what ZAGENO represents. Every touchpoint combination between scientists, vendors, and procurement needs a thoughtful, specific set-up to work effectively. To optimize, streamline and automate processes, every possible connection was rigorously analyzed, and their resulting scenarios examined. In combination with profound industry insights, the findings helped formulate ZAGENO's dynamic, market-leading set-up. ZAGENO's approach enables smooth, logical integration with all IT systems commonly used in the biotech e-commerce sector and particularly procurement departments. Biotechnology vendors and companies benefit from ZAGENO's online platform by reaching potential customers during their decision-making and buying process. Biotech brands can utilize ZAGENO as an additional digital sales channel to increase their brand's reach in key markets across the USA and Europe, strengthen brand awareness, and promote a positive brand image.

From unconnected stakeholders to integrated biotech industry members
"The entire online process of information gathering, ordering, and order approving within the life science and biotechnology sector is lacking coherence and ease," says Kilian Veer, Chief Operating Officer at ZAGENO Inc. "Maverick ordering is the only method a majority of scientists and laboratories can use to purchase research materials online because there is no other option available helping scientists to make purchasing decisions and streamline administrative order processes," he continues. "With ZAGENO," says Kilian, "we offer an ecosystem to connect all stakeholders via one single platform enabling quick purchasing decisions as well as coherent order information and tracking."

About ZAGENO Inc.
Since its formation in 2015, ZAGENO Inc. has set new standards in the international biotech market. With the vision to offer an online marketplace connecting scientists, academic research institutes, and biotech manufacturers, ZAGENO is growing exponentially and represents a milestone for the digitization of science and research. World-renowned research facilities use ZAGENO for ordering lab equipment and for optimizing internal processes. The start-up employs 47 staff members in Boston (USA) and Berlin (Germany). These two locations were selected for their proximity to renowned institutions known for their research advancements and scientific breakthroughs. For more EUREKA-moments - Welcome to ZAGENO: https://zageno.com

Company Contact:
Gesa Schramme,
VP Digital Growth
ZAGENO Inc.
pr@zageno.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/af5e50c1-2fda-4001-8a2e-eb84e7269a0b




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ZAGENO, Inc. via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

VITEC's EZ TV Video Wall Solution Wins Best of Show Award at the 2018 NAB Show26.4.2018 19:00Pressemelding

VITEC's EZ TV Video Wall Solution Wins Best of Show Award at the 2018 NAB Show SUNNYVALE, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- VITEC, a worldwide leader in advanced video encoding and streaming solutions, today announced that the new EZ TV video wall processor, available within the award-winning EZ TV IPTV and Digital Signage Platform, was recognized with a Best of Show Award at the 2018 NAB Show from Sound & Video Contractor (SVC) magazine. Evaluated by a panel of industry experts, the Best of Show Award winners were selected based on innovation, feature set, cost efficiency, and performance in serving the industry. VITEC's video wall solution is designed to simplify deployment and management of projects involving IPTV, digital signage, and video wall content, while delivering a breathtaking visual experience. The new EZ TV video wall processors are 100 percent hardware-based, feature low-latency native playback of IPTV streams up to 4K, and support interactive content, video, a

Inspiration in Receipt of Crypto Currency Proposal26.4.2018 16:54Pressemelding

TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Inspiration Mining Corporation ("Inspiration" or the "Corporation") (CSE:ISM) is pleased to announce that it is contemplating upon the request of Compassion Cannabis that it is allowed to accept crypto currency for settlement for any transactions that occur. The logic is that it would make for easy settlement in any jurisdiction. The Company is not adverse to this proposal, but must perform its due diligence and will table the matter at the AGM. Compassion Cannabis is an Ontario Corp., which has expertise to forward various facets of the explosive new market of the marijuana industry, including but not limited to the "Vape" market and dispensary centers for the industry. We believe this will be an extremely lucrative space with tremendous demand in the medical cannabis industry. For further information, please contact Randy Miller, Chief Executive Officer of the Corporation, at tel: 416-842-9000, www.inspirationmining.com The CSE has not revi

SNOMED International Announces Brazil as its 33rd Member26.4.2018 15:12Pressemelding

London, United Kingdom, April 26, 2018 (GLOBE NEWSWIRE) -- Brazil's Ministry of Health and SNOMED International announce that as of April 1, 2018, Brazil has joined the organization as SNOMED International's thirty-third Member. With SNOMED CT already used in various parts of the country, Brazil joined SNOMED International to support nationwide health system transformation as a foundational element of its ehealth Strategy, digiSUS. As outlined in this national strategy, the SUS Monitoring and Evaluation Department of Brazil's Ministry of Health is responsible overall for governance of the National Electronic Health Strategy and its related evaluation and development. Demonstrated through its membership in SNOMED International, Brazil has defined SNOMED CT as the chosen international reference terminology for use in its clinical systems supporting the national ehealth strategy. SNOMED CT is the world's most comprehensive health terminology. Founded in 2007 by nine charter nations, SNOME

Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 201826.4.2018 14:30Pressemelding

Management to host conference call WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the first quarter of 2018 on Thursday, May 3, 2018. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 for domestic callers or (765) 507-2618 for international callers and referring to conference ID number 8885379. A live webcast of the conference call will be available online in the Investors and Media section of the Company's website at ir.minervaneurosciences.com. The archived webcast will be available on the Company's website beginning approximately two hours after the event for 30 days. About Minerva Neurosciences Mine

Talend Data Fabric Now Certified on MapR Converged Data Platform Version 6.026.4.2018 14:11Pressemelding

Latest Release of Talend's Data Integration Platform Enables Powerful New Use Cases in Data Privacy, Compliance Monitoring, Claims Processing, Retail Optimization, and More REDWOOD CITY, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Talend (NASDAQ: TLND), a global leader in cloud and big data integration solutions, announced that the latest version of Talend Data Fabric is now certified for version 6.0 of the MapR Converged Data Platform, including MapR-DB and MapR-FS. The MapR Converged Data Platform is the industry's only enterprise-grade software solution that unifies big data and open source technologies with fast, native access to global event streaming, real-time database capabilities, and web-scale storage. Together, Talend and MapR provide a unified, open source-based data storage and management platform for an array of different applications, enabling organizations to harness big data in valuable ways to drive innovation and further their digital transformations. "Talend's powerf

CrownBio Launches New Humanized Target Model for Immunotherapy26.4.2018 14:00Pressemelding

SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, enhances its existing portfolio of humanized drug target models (HuGEMM(TM)) by launching a new transgenic CD3E model to advance development of immuno-oncology (I/O) drugs. Novel therapeutic T-cell redirecting antibodies, including bispecific T cell engagers, show great promise in effectively treating cancer. However, development of these drugs is hampered by a lack of in vivo models that can accurately recapitulate human specific responses. CrownBio addresses this need with their new CD3E transgenic model that was validated in collaboration with and developed by NBRI of Nanjing University. The CD3E model expresses the human form of CD3E and is phenotypically normal with levels

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom